Todos os produtos listados são exclusivamente para fins de pesquisa científica — não para consumo humano.
Brasil Peptide Guide
Weight Loss Research

Ipamorelin

Selective GH secretagogue studied for clean pulsatile GH release without cortisol or prolactin elevation seen with older GHRP compounds. Most commonly combined with CJC-1295 for synergistic GH secretion up to 5× greater than either alone.

2 fornecedores Brasil·1 com envio para o Brasil
Composto de pesquisa: Ipamorelin é vendido para fins de pesquisa científica. Não é um medicamento aprovado. Os efeitos descritos são baseados em pesquisa pré-clínica e (quando disponível) clínica publicada — não substitui orientação médica.

O que a Pesquisa Mostra

Studied for selective GHS-R1a agonism producing pulsatile GH secretion without ACTH, cortisol, or prolactin elevation. Studies measure serum GH AUC (serial sampling), IGF-1, and body composition. In combination with CJC-1295 produces 2–5× greater GH pulse than monotherapy with preserved selectivity.

Prós e Contras

Vantagens
  • +AOD-9604 received FDA GRAS (Generally Recognised As Safe) status for oral use — favourable regulatory safety signal
  • +CJC-1295 DAC requires only once-weekly dosing due to its 6–8 day half-life — highly convenient vs. daily protocols
  • +Ipamorelin is the most selective GH secretagogue available: no cortisol, prolactin, or ACTH elevation at standard doses
  • +CJC-1295 has published Phase I and II human trial data with well-characterised GH/IGF-1 pharmacokinetics
  • +AOD-9604 selectively activates β3 receptors in fat cells without binding IGF-1 receptors — no anabolic side-effects
  • +Combination of CJC-1295 + Ipamorelin produces 2–5× greater GH pulse than either compound alone
Limitações e Riscos
  • All three compounds require subcutaneous injection — no oral route with established human bioavailability
  • CJC-1295 substantially raises IGF-1 levels: blood glucose monitoring is advisable, especially for pre-diabetic individuals
  • AOD-9604 Phase III obesity trials showed limited efficacy at the doses tested orally — systemic injectable effects differ
  • Body composition improvements require consistent use over weeks to months — not a rapid intervention
  • Brasil availability is currently limited: only Particle Peptides consistently stocks all three in 2026
  • GH elevation during sleep can disrupt sleep architecture if dosed too close to bedtime

Cronologia de Efeitos

Baseado nos cronogramas de estudos publicados. A extrapolação para humanos é aproximada — os resultados individuais variam significativamente.

Início
Weeks 2–4
Efeito Máximo
Weeks 6–12
Contexto

GH serum elevation from CJC-1295 is detectable within 24 hours of first injection. Measurable body composition changes (DXA-measured fat mass reduction) in animal models require 4–6 weeks at minimum. Human self-researcher timelines are typically 8–12 weeks before significant changes in body composition become visible.

Para que se Pesquisa

Stubborn body fat reduction, particularly visceral/abdominal fat
Improving body composition ratio (lean mass vs fat mass)
Growth hormone optimisation without exogenous HGH
CJC-1295 + Ipamorelin combination stack for synergistic GH secretion
Metabolic rate and fat oxidation research
Recovery and sleep quality improvement (GH pulses occur during deep sleep)
Status Legal no Brasil: AOD-9604 is unscheduled and not a controlled substance in Brazil. CJC-1295 and Ipamorelin are on the WADA Prohibited List (S2 — Peptide Hormones) for competitive athletes. They are not approved medicines in Brazil or USA. Purchase as research compounds is legal in Brazil for non-competitive research purposes. Athletes subject to testing should be aware of detection windows.

Perguntas Práticas

Apenas para fins educativos. A autoadministração de compostos de pesquisa acarreta riscos significativos. Consulte um profissional qualificado.

When is the best time to inject CJC-1295 + Ipamorelin?

Published animal studies and the CJC-1295 Phase I trial use a single weekly or biweekly SC injection without time-of-day specification. The self-research community commonly doses Ipamorelin immediately before sleep, as natural GH secretion is highest during slow-wave sleep — and GH secretagogues amplify this natural pulse. CJC-1295 DAC is typically injected once weekly at any time due to its extended half-life.

Is AOD-9604 a safer alternative to HGH for fat loss?

AOD-9604 was specifically engineered to retain the lipolytic (fat-burning) activity of growth hormone while eliminating its anabolic and diabetogenic effects. It does not bind the IGF-1 receptor and does not significantly alter blood glucose in published studies — key advantages over full-length HGH. However, "safer" must be understood in context: AOD-9604 has no long-term human safety data for injectable use, and the FDA GRAS designation applies to an oral formulation, not injectable.

Do I need to cycle off CJC-1295 and Ipamorelin?

Published human trials ran for 4–6 weeks without tolerance or desensitisation issues. The self-research community commonly uses 3-month on / 1-month off cycles, though this is convention rather than evidence-based protocol. There is theoretical concern that chronic GHRH receptor stimulation could cause pituitary desensitisation over very long periods — a risk that has not been systematically studied at research peptide doses.

Onde Comprar Ipamorelin no Brasil

2 fornecedores acessíveis no Brasil têm Ipamorelin em estoque atualmente, incluindo 1 com envio verificado para o Brasil. Compare preços e disponibilidade abaixo.